Related Experiment Video
Updated: Feb 5, 2026

Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis NASH Resolution
Published on: April 16, 2019
NASH: The Emerging Most Common Form of Chronic Liver Disease
Meron Tesfay1, W Joseph Goldkamp2, Brent A Neuschwander-Tetri3
1Meron Tesfay, MD, is Fellow in Gastroenterology, at Saint Louis University School of Medicine, St. Louis, Mo.
Abstract:
Nonalcoholic steatohepatitis (NASH) is a common cause of chronic liver disease that can progress to cirrhosis and hepatocellular carcinoma. This review provides brief answers to common questions clinicians may have about NASH. The diagnosis of NASH currently requires a liver biopsy, although non-invasive tests are being evaluated and may supplant liver biopsy in the near future. Treatment is focused on lifestyle modifications, with new medications currently in clinical trials.
More Related Videos
Related Concept Videos
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Chronic Kidney Disease I: Introduction
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation

